AdaptHealth (NASDAQ:AHCO) Rating Increased to Buy at Wall Street Zen

AdaptHealth (NASDAQ:AHCO) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

A number of other equities analysts also recently weighed in on AHCO. Royal Bank Of Canada cut their price target on shares of AdaptHealth from $14.00 to $13.00 and set an “outperform” rating on the stock in a report on Thursday, May 8th. Truist Financial cut their price target on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a report on Monday, May 12th. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth currently has an average rating of “Buy” and a consensus target price of $13.40.

AdaptHealth Price Performance

AHCO opened at $9.19 on Friday. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.06 and a quick ratio of 1.07. The company has a market capitalization of $1.24 billion, a price-to-earnings ratio of 17.02, a P/E/G ratio of 0.89 and a beta of 1.58. The firm’s fifty day moving average price is $9.09 and its two-hundred day moving average price is $9.32. AdaptHealth has a 1 year low of $7.11 and a 1 year high of $11.70.

Institutional Investors Weigh In On AdaptHealth

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. AlphaQuest LLC raised its stake in AdaptHealth by 275.7% in the 2nd quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock valued at $37,000 after acquiring an additional 2,892 shares during the period. Assetmark Inc. increased its position in shares of AdaptHealth by 87.6% during the second quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock valued at $52,000 after buying an additional 2,581 shares during the period. GAMMA Investing LLC increased its position in shares of AdaptHealth by 175.2% during the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company’s stock valued at $81,000 after buying an additional 4,758 shares during the period. Brooklyn Investment Group increased its position in shares of AdaptHealth by 531.8% during the first quarter. Brooklyn Investment Group now owns 7,563 shares of the company’s stock valued at $82,000 after buying an additional 6,366 shares during the period. Finally, CWM LLC increased its position in shares of AdaptHealth by 1,562.1% during the second quarter. CWM LLC now owns 10,471 shares of the company’s stock valued at $99,000 after buying an additional 9,841 shares during the period. 82.67% of the stock is currently owned by institutional investors.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.